Aug. 28, 2015

How Plaquenil® May Help Prevent Heart Damage in Newborns

Under Investigation: Preventive care on the horizon

Aug. 13, 2015

How Do We Think About Lupus and Why Does it Matter?

Not all patients who share a certain organ involvement can be treated with the same medicine at the same dose. In this piece, Foundation Medical Director Dr. Joan Merrill argues that improved classification of lupus can lead to better treatment.

Aug. 03, 2015

Regulations for Off-Label Drugs Must Change

Off-label drugs for the treatment of lupus symptoms represents the standard of care for people with lupus, but current regulations make it difficult for doctors and manufacturers to communicate. Read Sandra C. Raymond's remarks now.

Jul. 28, 2015

Statement on the Results of Epratuzumab Study for the Treatment of Lupus

Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO

Jul. 10, 2015

U.S. House of Representatives Passes 21st Century Cures Act

Jul. 01, 2015

Dr. George C. Tsokos Selected as 2015 Recipient of the Lupus Insight Prize

George C. Tsokos, M.D., Chief of the Rheumatology Division at Beth Israel Deaconess Medical Center and Professor of Medicine, Harvard Medical School, has been selected as the 2015 recipient of the Lupus Insight Prize.

Apr. 01, 2015

Preliminary Results Showcase Success of New Lupus Foundation of America Initiative

LFA-REAL aims to improve health and quality of life for people with lupus.

Apr. 01, 2015

People With Lupus Must Have Access to Prescription Drugs

People with lupus need and deserve a full arsenal of treatments. With many new and innovative drugs for lupus in the drug pipeline, these highly anticipated treatments will mean nothing if people with lupus cannot afford them.